NUVECTIS PHARMA INC's ticker is and the CUSIP is 67080T108. A total of 14 filers reported holding NUVECTIS PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BALDWIN BROTHERS LLC/MA | 143,800 | $1,885,218 | 0.16% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 24,570 | $322,113 | 0.01% |
| Man Group plc | 12,840 | $168,332 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 164 | $2,150 | 0.00% |
| WELLS FARGO & COMPANY/MN | 25 | $328 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 35,022 | $459,138 | 0.00% |
| STATE STREET CORP | 13,400 | $175,674 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 24,667 | $323 | 0.00% |
| MORGAN STANLEY | 3,115 | $40,838 | 0.00% |
| BlackRock Inc. | 13,556 | $177,720 | 0.00% |
| Tower Research Capital LLC (TRC) | 250 | $3 | 0.00% |
| VANGUARD GROUP INC | 201,433 | $2,640,786 | 0.00% |
| JANE STREET GROUP, LLC | 11,086 | $145,337 | 0.00% |
This page lists NUVECTIS PHARMA INC's shareholders in Q1 2023. To view NUVECTIS PHARMA INC's shareholder history, click here.